Bladder Cancer - Results from #160

Characterization of Cellular and Acellular Analytes from Pre-Cystectomy Liquid Biopsies in Patients Newly Diagnosed with Primary Bladder Cancer. February 22, 2022

Re-engineered BCG overexpressing cyclic di-AMP augments trained immunity and exhibits improved efficacy against bladder cancer. February 22, 2022

Diagnostic accuracy of vesical imaging-reporting and data system (VI-RADS) for the detection of muscle-invasive bladder cancer: a meta-analysis. February 22, 2022

Carboplatin-based adjuvant chemotherapy versus observation after radical cystectomy in patients with pN1-3 urothelial bladder cancer. February 21, 2022

The Role of New Technologies in the Diagnosis and Surveillance of Non-Muscle Invasive Bladder Carcinoma: A Prospective, Double-Blinded, Monocentric Study of the XPERT© Bladder Cancer Monitor and Narrow Band Imaging© Cystoscopy. February 21, 2022

Incidence of bladder cancer in neuro-urological patients in France: a nationwide study. February 21, 2022

Long term cost comparisons of radical cystectomy versus trimodal therapy for muscle-invasive bladder cancer. February 18, 2022

Cruciferous Vegetable Intervention to Reduce the Risk of Cancer Recurrence in Non-Muscle-Invasive Bladder Cancer Survivors: Development Using a Systematic Process. February 18, 2022

Prognostic Impact of CD36 Immunohistochemical Expression in Patients with Muscle-Invasive Bladder Cancer Treated with Cystectomy and Adjuvant Chemotherapy. February 17, 2022

Associations between Dietary Patterns and Malnutrition, Low Muscle Mass and Sarcopenia in Adults with Cancer: A Scoping Review. February 17, 2022

A Comprehensive Approach to Clinical Staging of Bladder Cancer. February 17, 2022

The Accuracy of Transurethral Bladder Resection in Detecting Bladder Cancer Histological Variants and Their Prognostic Value at Radical Cystectomy. February 17, 2022

New Perspectives in the Medical Treatment of Non-Muscle-Invasive Bladder Cancer: Immune Checkpoint Inhibitors and Beyond. February 17, 2022

Xpert Bladder Cancer Monitor May Avoid Cystoscopies in Patients Under "Active Surveillance" for Recurrent Bladder Cancer (BIAS Project): Longitudinal Cohort Study. February 16, 2022

Continent cutaneous urinary diversion with an ileal pouch with the Mitrofanoff principle versus a Miami pouch in patients undergoing cystectomy for bladder cancer: results of a comparative study. February 16, 2022

microRNA-99a-5p induces cellular senescence in gemcitabine-resistant bladder cancer by targeting SMARCD1. February 15, 2022

EGFR-Targeted ImmunoPET of UMUC3 Orthotopic Bladder Tumors. February 15, 2022

Impact of carcinoma in situ on the outcome of intravesical Bacillus Calmette-Guérin therapy for non-muscle-invasive bladder cancer: a comparative analysis of large real-world data. February 14, 2022

Early-Line Infigratinib for Patients with FGFR3-Altered Metastatic Urothelial Carcinoma - Expert Commentary February 11, 2022

A study of the immunohistochemical profile of bladder cancer in neuro-urological patients by the French Association of Urology. February 11, 2022

Page 9 of 428

email news signup